About the Prostate Cancer Session
Prostate cancer remains a significant focus in cancer research due to its prevalence and impact on men's health. Studies delve into various aspects, from understanding its molecular mechanisms to refining diagnostic techniques and treatment options. Researchers explore genetic factors influencing prostate cancer risk and progression, paving the way for personalized medicine approaches. Advanced imaging technologies aid in early detection and monitoring, crucial for improving survival rates. Additionally, immunotherapy and targeted therapies show promise in enhancing treatment efficacy with fewer side effects. Collaborative efforts between scientists, clinicians, and patients drive progress in prostate cancer research, aiming for better outcomes and quality of life for affected individuals. As research continues to evolve, the future holds prospects for more effective prevention, detection, and treatment strategies in combating this prevalent disease.
Topics Covered in Prostate Cancer
PSA Screening
MRI-Targeted Biopsy
Active Surveillance
Androgen Deprivation
PSMA PET Imaging
Castration Resistance
Related Scientific Sessions at CIOC 2027
Why Attend the Prostate Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Prostate Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Prostate Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Prostate Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Prostate Cancer Conference 2027 — FAQs
What is the Prostate Cancer track at CIOC 2027?
The Prostate Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Prostate Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Prostate Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Prostate Cancer are all welcome — whether presenting or attending.
Can I present my research in the Prostate Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Prostate Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Prostate Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.